Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.
- DOI
- 10.1128/aac.04383-14
- Published
- 2015 Feb
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.04383-14,
title = {Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.},
author = {Zeuzem S and Soriano V and Asselah T and Gane EJ and Bronowicki JP and Angus P and Lohse AW and Stickel F and Müllhaupt B and Roberts S and Schuchmann M and Manns M and Bourlière M and Buti M and Stern JO and Gallivan JP and Voss F and Sabo JP and Böcher W and Mensa FJ and SOUND-C2 Study Group},
year = {2015},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.04383-14},
url = {https://doi.org/10.1128/aac.04383-14}
}RIS
TY - JOUR TI - Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis. AU - Zeuzem S AU - Soriano V AU - Asselah T AU - Gane EJ AU - Bronowicki JP AU - Angus P AU - Lohse AW AU - Stickel F AU - Müllhaupt B AU - Roberts S AU - Schuchmann M AU - Manns M AU - Bourlière M AU - Buti M AU - Stern JO AU - Gallivan JP AU - Voss F AU - Sabo JP AU - Böcher W AU - Mensa FJ AU - SOUND-C2 Study Group PY - 2015 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.04383-14 UR - https://doi.org/10.1128/aac.04383-14 ER -
APA
S, Z., V, S., T, A., EJ, G., JP, B., P, A., AW, L., F, S., B, M., S, R., M, S., M, M., M, B., M, B., JO, S., JP, G., F, V., JP, S., W, B., FJ, M., & Group, S. S. (2015). Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.04383-14
Source records
- pubmed · retrieved 2026-09-27T08:45:42.826Z